quick search
Today:
Home AI

More Articles

Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens

Jan 8, 2025

HONG KONG,Jan. 7,2025-- Eyebright Medical Technology (Beijing) Co.,Ltd. ("Eyebright Medical",the "Company",Stock Code: 688050.SH,together with its subsidiaries collectively known

BIPO Strengthens Global HR Tech Leadership with Third Recognition in Everest Group's PEAK Matrix® Assessment

Jan 8, 2025

SINGAPORE,Jan. 7,2025-- BIPO,a leading global HR technology and services provider,has been recognised as a Major Contender in the Everest Group Multi-Country Payroll (MCP) Solutions PEAK Matrix®

Moomoo Announces Global Partnership With Seeking Alpha to Amplify Trading Potential for Investors

Jan 8, 2025

JERSEY CITY,N.J.,Jan. 7,2025-- Moomoo,one of the world\'s leading investment and trading platforms,today announced its partnership with Seeking Alpha,a leading financial research platform powered by

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Jan 8, 2025

TAMPA,Fla.,Jan. 7,2025-- Concept Medical Inc.,a global leader in innovative drug-delivery technology,proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Pac

Eighteen New Semiconductor Fabs to Start Construction in 2025, SEMI Reports

Jan 8, 2025

MILPITAS,Calif.,Jan. 7,2025-- The semiconductor industry is expected to start 18 newfab construction projectsin 2025*,according to SEMI\'s latest quarterly World Fab Forecast report. The new projects

Linker Vision Unveils the Future of Smart Cities at CES 2025: Showcasing Innovative VLM and GenAI

Jan 8, 2025

LAS VEGAS,Jan. 8,2025-- Linker Vision revealed its groundbreaking technologies at CES 2025,featuring its latest GenAI Observ platform,VLM (Vision Language Model),and LVM (Large Vision Model). The comp

Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease

Jan 8, 2025

Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups,demonstrating a favorable PK profile in validating gut-r

GIGABYTE Unveils a diverse lineup of AI PCs with Groundbreaking GiMATE AI Agent at CES 2025

Jan 8, 2025

TAIPEI,Jan. 8,2025-- GIGABYTE,the world\'s leading computer brand,unveiled its next-gen AI PCs at CES 2025. GiMATE,a groundbreaking AI agent for seamless hardware and software control,takes center sta

Consumer Technology Association Announces New Global Innovation Champions

Jan 8, 2025

Global Innovation Scorecard highlights countries that excel in broadband,autonomous vehicles,blockchain and more

LingoAce Launches Ace Academy Learning Centers in the United States and Australia

Jan 8, 2025

SINGAPORE and NEW YORK,Jan. 7,2025-- LingoAce,the global leader in online education for children with award-winning learning programs in Mandarin Chinese,English,and math,today announces the launch of

1 ... 28 29 30 31 32 33 34 ... 111

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs